0001636282-26-000068.txt : 20260529 0001636282-26-000068.hdr.sgml : 20260529 20260529175632 ACCESSION NUMBER: 0001636282-26-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260527 FILED AS OF DATE: 20260529 DATE AS OF CHANGE: 20260529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Albers Jeffrey W. CENTRAL INDEX KEY: 0001638474 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 261046467 MAIL ADDRESS: STREET 1: C/O ATLAS VENTURE STREET 2: 300 TECHNOLOGY SQ, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spyre Therapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6176515940 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc. DATE OF NAME CHANGE: 20150311 4 1 wk-form4_1780091789.xml FORM 4 X0609 4 2026-05-27 0 0001636282 Spyre Therapeutics, Inc. SYRE 0001638474 Albers Jeffrey W. false 221 CRESCENT STREET, BUILDING 23, SUITE 105 WALTHAM MA 02453 1 0 0 0 0 Stock Option (Right to Buy) 72.51 2026-05-27 4 A 0 8026 0 A 2036-05-27 Common Stock 8026 8026 D This option represents a right to purchase 8,026 shares of the Issuer's common stock, which will vest and become fully exercisable upon the earlier of May 27, 2027 or the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date. /s/ Heidy King-Jones, as Attorney-in-Fact 2026-05-29